Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A shift in lung macrophage composition is associated with COVID-19 severity and recovery. | Sci Transl Med | 2022 | 36103512 | PubTator, text mining | PubMed |
| Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. | J Clin Invest | 2022 | 36099049 | PubTator, text mining | PubMed |
| [Relationship between onco-immunological and morphologic characteristics of lymphoepithelioma-like carcinoma and lymphocyte subtypes of peripheral blood]. | Zhonghua Bing Li Xue Za Zhi | 2022 | 36097901 | PubTator, text mining | PubMed |
| Toll-like receptor signaling pathway triggered by inhibition of serpin A1 stimulates production of inflammatory cytokines by endometrial stromal cells. | Front Endocrinol (Lausanne) | 2022 | 36093086 | PubTator, text mining | PubMed |
| Advances in the Biology, Detection Techniques, and Clinical Applications of Circulating Tumor Cells. | J Oncol | 2022 | 36090904 | PubTator, text mining | PubMed |
| Systemic Delivery of mPEG-Masked Trispecific T-Cell Nanoengagers in Synergy with STING Agonists Overcomes Immunotherapy Resistance in TNBC and Generates a Vaccination Effect. | Adv Sci (Weinh) | 2022 | 36089659 | PubTator, text mining | PubMed |
| Randomized Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2831781 in Healthy Japanese and White Participants. | Clin Pharmacol Drug Dev | 2022 | 36088650 | PubTator, text mining | PubMed |
| LAG-3 as a Potent Target for Novel Anticancer Therapies of a Wide Range of Tumors. | Int J Mol Sci | 2022 | 36077354 | PubTator, text mining | PubMed |
| RNA Sequencing Demonstrates That Circular RNA Regulates Avian Influenza Virus Replication in Human Cells. | Int J Mol Sci | 2022 | 36077296 | PubTator, text mining | PubMed |
| Stromal Vascular Fraction Reverses the Age-Related Impairment in Revascularization following Injury. | J Vasc Res | 2022 | 36075199 | PubTator, text mining | PubMed |
| Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic data. | Front Immunol | 2022 | 36072597 | PubTator, text mining | PubMed |
| Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2. | Signal Transduct Target Ther | 2022 | 36071039 | PubTator, text mining | PubMed |
| Aerosolized Zika virus infection in Guinea pigs. | Emerg Microbes Infect | 2022 | 36069671 | PubTator, text mining | PubMed |
| Pyroptosis correlates with tumor immunity and prognosis. | Commun Biol | 2022 | 36068291 | PubTator, text mining | PubMed |
| Distinctive populations of CD4+T cells associated with vaccine efficacy. | iScience | 2022 | 36060075 | PubTator, text mining | PubMed |
| Time-resolved characterization of the innate immune response in the respiratory epithelium of human, porcine, and bovine during influenza virus infection. | Front Immunol | 2022 | 36059535 | PubTator, text mining | PubMed |
| The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors. | Front Immunol | 2022 | 36059512 | PubTator, text mining | PubMed |
| A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development. | BMC Public Health | 2022 | 36050659 | PubTator, text mining | PubMed |
| IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia. | J Clin Invest | 2022 | 36047494 | PubTator, text mining | PubMed |
| HIV-1 induction of tolerogenic dendritic cells is mediated by cellular interaction with suppressive T cells. | Front Immunol | 2022 | 36032117 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=43